Peptide services/genscript/parisa malekzadeh
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700371P
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,667
Award facts
- Contract value 100% obligated
- $3,666.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Genscript USA Inc. for $3,666.96 on June 28, 2017. Performance occurs in Piscataway, New Jersey. The order procures peptide services on a firm fixed price basis, with ultimate completion targeted for July 27, 2017.
Quick answers
Who was awarded contract HHSN261201700371P?
HHSN261201700371P was awarded to Genscript USA Inc. by National Cancer Institute (National Institutes of Health) on June 28, 2017.
How much is contract HHSN261201700371P worth?
The government has obligated $3,667 on HHSN261201700371P.
Was contract HHSN261201700371P competed?
The extent of competition for HHSN261201700371P was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award